Peter Ericsson | OMICS International

Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Peter Ericsson

Scientific Advisory Board


Dr. Peter Ericsson serves as Member of Scientific Advisory Board at Idogen AB and served as its CSO until July 6, 2016. Dr. Ericsson has the overall charge of research and development of Idogen. He has more than ten years of research experience covering both pharmacology, endocrinology and immunology, with special focus on dendritic cells, immune tolerance and immune suppressive mechanisms. Dr. Ericsson is employed as researcher at the department of clinical sciences at the Biomedical Center, Lund University. Dr. Ericsson holds a M.Sc. in biology and a Ph.D. in pharmacology from Lund University.

Research Interest
  • Neurosurgery
  • Rausing laboratory of Lund - Tumor section

Global Speakers in the subject

Global Experts in the subject